S-1 vs. paclitaxel plus carboplatin as adjuvant chemotherapy for completely resected stage�II/IIIA non‑small‑cell lung cancer

Author:

Okuda Katsuhiro1,Yano Motoki1,Tatematsu Tsutomu1,Nakamae Katsumi2,Yamada Takeshi3,Kasugai Toshio4,Nishida Tsutomu5,Sano Masaaki6,Moriyama Satoru1,Haneda Hiroshi1,Kawano Osamu1,Nakanishi Ryoichi1

Affiliation:

1. Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467‑8601, Japan

2. Department of Surgery, Nagoya West Medical Center, Nagoya, Aichi 462‑8508, Japan

3. Department of Surgery, Kariya Toyota General Hospital, Kariya, Aichi 448‑8505, Japan

4. Department of Surgery, Matsunami General Hospital, Hashima, Gifu 501‑6062, Japan

5. Department of Surgery, Toyokawa Hospital, Toyokawa, Aichi 442‑8561, Japan

6. Department of Surgery, Nagoya Memorial Hospital, Nagoya, Aichi 468‑8520, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3